文献速递其他结缔组织病

干燥病中的副蛋白血症:冷球蛋白血症与血清单克隆丙种球蛋白病界定不同临床表型及淋巴瘤易感性

Paraproteinemias in Sjögren disease: cryoglobulinemia and serum monoclonal gammopathy identify distinct clinical phenotypes and differential lymphoma susceptibility.
PubMed 文献 · Semin Arthritis Rheum · 2026-04-19

本研究基于意大利GRISS登记的多中心回顾性横断面研究,纳入1202例干燥病(SjD)患者,比较孤立单克隆丙种球蛋白病(MC)、孤立冷球蛋白血症(CRYO)、两者共存及对照组的表型与淋巴瘤风险。结果显示仅MC+CRYO组与淋巴瘤显著相关(OR 6.30,95%CI 2.66-14.92;p<0.001),冷球蛋白血症与血管炎表现及淋巴增殖标志物相关。

要点

  • MC+CRYO共存组淋巴瘤风险显著升高(OR 6.30),孤立MC或CRYO无此关联。
  • 冷球蛋白血症(孤立或合并MC)与类风湿因子阳性、低C4及血管炎表现相关。
  • MC+CRYO组还呈现体质性、腺体、血液学及淋巴结病等淋巴增殖表型。

核心结论

  • 干燥病中冷球蛋白血症与血管炎性疾病活动相关,而血清MC与冷球蛋白共存界定一个高风险亚群,以晚期B细胞扩增和淋巴瘤易感性增加为特征。

研究设计与样本

  • 意大利GRISS登记的多中心、回顾性、横断面研究,纳入1202例干燥病患者,分为孤立MC组(58例,4.83%)、孤立CRYO组(32例,2.66%)、MC+CRYO组(35例,2.91%)及对照组(1077例,89.60%)。

主要发现

  • 与对照组相比,仅MC+CRYO组与淋巴瘤显著相关(OR 6.30,95%CI 2.66-14.92;p<0.001),孤立MC和孤立CRYO组无显著关联。
  • 冷球蛋白血症(孤立或合并MC)与类风湿因子(p<0.001)、低C4(p<0.001)及ClinESSDAI血管炎特征相关,包括皮肤(p<0.001)、肾脏(p<0.05)和周围神经系统(p<0.001)域。
  • MC+CRYO组还显示与体质性(p<0.05)、腺体(p<0.05)、血液学(p<0.001)及淋巴结病(p<0.001)域相关的淋巴增殖表型。

关键数值与推荐

  • 淋巴瘤与MC+CRYO组关联的OR为6.30(95%CI 2.66-14.92;p<0.001),孤立MC和孤立CRYO组无显著关联。
  • 冷球蛋白血症与类风湿因子、低C4及ClinESSDAI血管炎域(皮肤p<0.001、肾脏p<0.05、周围神经系统p<0.001)相关。

临床怎么用

  • 对干燥病患者应检测血清单克隆丙种球蛋白和冷球蛋白,二者共存提示淋巴瘤高风险,需加强监测。
  • 冷球蛋白血症阳性患者应评估血管炎相关临床表现及淋巴增殖标志物。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sjögren disease (SjD) is a systemic autoimmune disease characterized by increased risk of B-cell non-Hodgkin lymphoma. Although cryoglobulinemia and serum monoclonal component (MC) are well-recognized paraproteinemias in SjD, no large-scale study has directly compared their isolated and combined impact on phenotype and lymphoproliferative risk. METHODS: A retrospective, multicenter, cross-sectional study was conducted within the Italian GRISS registry. Patients with SjD were stratified into four groups: isolated monoclonal gammopathy (MC-alone), isolated cryoglobulinemia (CRYO-alone), both (MC+CRYO), or neither (controls). Demographics, lymphoma history, ever-documented ClinESSDAI domains, and laboratory lymphoproliferative risk-related markers were analyzed. Primary and secondary outcomes assessed lymphoma diagnosis and the distribution of laboratory lymphoproliferative risk-related markers and ClinESSDAI domains across groups, with associations tested using logistic regression adjusted for confounders. RESULTS: 1202 SjD patients were enrolled: 58 (4.83%) in the MC-alone, 32 (2.66%) in the CRYO-alone, 35 (2.91%) in the MC+CRYO, and 1077 (89.60%) controls. Compared with controls, only the MC+CRYO group showed significant association with lymphoma (OR 6.30, 95%CI 2.66-14.92; p < 0.001), while MC-alone and CRYO-alone were not associated. Cryoglobulinemia, alone or combined with MC, correlated with laboratory lymphoproliferative risk-related markers such as rheumatoid factor (p < 0.001) and low C4 (p < 0.001), and with ClinESSDAI vasculitic features (cutaneous [p < 0.001], renal [p < 0.05], PNS [p < 0.001]). The MC+CRYO group additionally displayed a lymphoproliferative phenotype correlating with constitutional (p < 0.05), glandular (p < 0.05), hematological (p < 0.001), and lymphadenopathy (p < 0.001) domains. CONCLUSION: Cryoglobulinemia in SjD associates with vasculitic disease activity, whereas the coexistence of serum MC and cryoglobulins identifies a distinct, high-risk subset characterized by advanced B-cell expansion and increased lymphoma susceptibility.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Longhino S, Rizzo MT, Manfrè V, et al. Paraproteinemias in Sjögren disease: cryoglobulinemia and serum monoclonal gammopathy identify distinct clinical phenotypes and differential lymphoma susceptibility. Semin Arthritis Rheum. 2026. PMID: 42030799. doi:10.1016/j.semarthrit.2026.152986

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。